| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2001 | CN1301692A Higher fatty alcohol aliphatic ester and use thereof |
| 07/04/2001 | CN1301691A New L-threonic acid derivatives |
| 07/04/2001 | CN1301558A Compound ginkgo health product and preparing method |
| 07/04/2001 | CN1301556A 三七软胶囊 Thirty-seven soft capsules |
| 07/04/2001 | CN1301547A Analgesic plaster for osteoarthritis |
| 07/04/2001 | CN1301543A Skin external use agent |
| 07/04/2001 | CN1301536A Bee pollination inducing agent |
| 07/04/2001 | CN1301535A Use of curcumin to treat hepatitis B |
| 07/04/2001 | CN1301534A Stable slow-releasing oral administration composition |
| 07/04/2001 | CN1068003C Mesoplatinum complex and its synthesis |
| 07/04/2001 | CN1068001C Heterocycle substituted propenoid acid derivatives as NMDA antagonists |
| 07/04/2001 | CN1068000C Apolioprotein -B synthesis inhibitors |
| 07/04/2001 | CN1067999C Anti-helicobacter heterocyclic derivatives of azolines |
| 07/04/2001 | CN1067998C Hydrate for medicinal use |
| 07/04/2001 | CN1067997C Process for preparing propionitaxiene -13 alpha ester trihydrate |
| 07/04/2001 | CN1067996C Method for preparing propionitaxiene ester trihydrate |
| 07/04/2001 | CN1067992C Substituted thiazolidine derivatives and pharmaceutical compounds containing them and use thereof |
| 07/04/2001 | CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds |
| 07/04/2001 | CN1067989C New compound with analgesic and local anaesthetic effect |
| 07/04/2001 | CN1067987C 取代的吲哚衍生物 Substituted indole derivatives |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/04/2001 | CN1067976C Asiatic acid derivatives its manufacturing method and dermatological agent containing it |
| 07/04/2001 | CN1067902C Decrustation ointment for burn and its preparing process |
| 07/04/2001 | CN1067897C Medicine for cleaning scar and stain on skin |
| 07/04/2001 | CN1067895C Chinese and western medicinal preparation for curing hand and foot tinea and preparing method thereof |
| 07/04/2001 | CN1067888C Liquid for curing hepatitis and its preparing method |
| 07/04/2001 | CN1067879C Preparation for curing dermatomycosis |
| 07/04/2001 | CN1067875C Estradiol weekly-acting percutaneous absorption adhesive plaster |
| 07/03/2001 | US6255517 Thymol derivatives having anti-tumor activity, and anti-cancer agent comprising the same |
| 07/03/2001 | US6255512 High energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, andpharmaceutical agents |
| 07/03/2001 | US6255502 Pharmaceutical composition containing acid addition salt of basic drug |
| 07/03/2001 | US6255501 Process for preparing antiosteoporotic agents |
| 07/03/2001 | US6255495 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups and method of application thereof |
| 07/03/2001 | US6255494 Substituted benzimidazoles useful in treating or preventing conditions associated with excess of neuropeptide y (around arteries in heart, respiratory tract, gastrointestinal tract and genitourinary tract); etiology of psychiatric disorders |
| 07/03/2001 | US6255490 Treating disorders associated with changes in cholinergic activity; non-opiate based analgesic for moderate to severe pain equally or exceeding the potency of opiate analgesics, yet lacking addictive side effects |
| 07/03/2001 | US6255485 Purine inhibitors of protein kinases, G proteins and polymerases |
| 07/03/2001 | US6255481 Treating aqueous suspension of anhydrous nevirapine with hydrochloric acid then treating with sodium hydroxide yields the free base as a precipitate/hemihydrate which is then filtered from solution and water washed |
| 07/03/2001 | US6255480 Aminothiazole derivatives useful in the preparation of β-lactam antibiotics |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255467 Human blood bacterium |
| 07/03/2001 | US6255421 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 07/03/2001 | US6255355 Method of inhibiting angiogenesis |
| 07/03/2001 | US6255353 Inhibition of angiogenesis |
| 07/03/2001 | US6255351 Treatment of bone disorders |
| 07/03/2001 | US6255349 Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255347 Methods and compositions comprising R-ibuprofen |
| 07/03/2001 | US6255346 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects |
| 07/03/2001 | US6255345 GABA and L-glutamic acid analogs for antiseizure treatment |
| 07/03/2001 | US6255341 Nutrients; mixture of vitamins, triglycerides and protein |
| 07/03/2001 | US6255338 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors |
| 07/03/2001 | US6255336 Amino ceramide-like compounds and therapeutic methods of use |
| 07/03/2001 | US6255335 Substituted 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides |
| 07/03/2001 | US6255334 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
| 07/03/2001 | US6255332 Use of oxazolidinone derivatives as anti-penetrating agents in a cosmetic and/or dermatological composition |
| 07/03/2001 | US6255329 Combined use of pramipexole and sertraline for the treatment of depression |
| 07/03/2001 | US6255327 Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions |
| 07/03/2001 | US6255325 Chronic, bolus administration of D-threo methylphenidate |
| 07/03/2001 | US6255320 Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 07/03/2001 | US6255319 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands |
| 07/03/2001 | US6255318 Antiviral compounds |
| 07/03/2001 | US6255317 Cholesterol biosynthesis inhibitors |
| 07/03/2001 | US6255316 Crystal structure |
| 07/03/2001 | US6255314 Cancerous metastasis inhibitors containing uracil derivatives |
| 07/03/2001 | US6255308 Treatment of equine protozoal myeloencephalitis |
| 07/03/2001 | US6255307 Pyrazine compounds |
| 07/03/2001 | US6255306 4-indole derivatives as serotonin agonists and antagonists |
| 07/03/2001 | US6255305 Substituted triazolo-pyridazine derivatives as ligands for GABA receptors |
| 07/03/2001 | US6255303 Bronchodilator agent |
| 07/03/2001 | US6255299 Opthalmic gel composition and method of treating eye infections |
| 07/03/2001 | US6255298 Using an aromatic amide compound |
| 07/03/2001 | US6255297 Salicylic acid derivatives and their use in cosmetic or dermatological compositions |
| 07/03/2001 | US6255296 Composition and method for treating a patient susceptible to or suffering from a cardiovascular disorder or disease |
| 07/03/2001 | US6255294 Absorption by mucous membrane |
| 07/03/2001 | US6255291 Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
| 07/03/2001 | US6255290 Reducing sensitivity to skin cancer; topical administering of nucleotide |
| 07/03/2001 | US6255288 Therapy for bone disorders |
| 07/03/2001 | US6255287 Livestock feedlot adaptation treatment method and product |
| 07/03/2001 | US6255279 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 07/03/2001 | US6255277 Localized use of nitric oxide-adducts to prevent internal tissue damage |
| 07/03/2001 | US6255105 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/03/2001 | US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities |
| 07/03/2001 | US6255091 Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions |
| 07/03/2001 | US6255072 Nucleotide sequences coding proteolytic polypeptide; for use as diagnostic tool; for the prevention of bacterial infection |
| 07/03/2001 | US6255046 Drug screening of enzyme inhibitors by expressing enzyme or kinase domain, purifying, isolating, adding test compound and fructose 6-phosphate, and measuring formation of fructose 2,6 bisphosphate product; reduction indicates candidate |
| 07/03/2001 | US6254904 Comprising: (6s)-tetrahydrofolic acid and derivatives and polyglutamyl derivatives; multivitamin breakfast foods, infant formulas, dietary supplements and animal feed preparation |
| 07/03/2001 | US6254899 Plant extract compositions, method of preparation, and pharmaceutical compositions containing them |
| 07/03/2001 | US6254893 Calcium-based ophthalmic composition including a hydrophobic carrier, such as petrolatum, and a calcium salt, sufficiently viscous to prevent dripping or running after application to the skin adjacent the eyelids |
| 07/03/2001 | US6254887 Controlled release tramadol |
| 07/03/2001 | US6254885 Containing: cyclosporin, ethanol or propylene glycol, non-ionic polyoxyalkylene surfactant, cosolvent; high bioavailability, used in immuno-suppressive therapy |
| 07/03/2001 | US6254883 Composition for transdermal delivery of drugs |
| 07/03/2001 | US6254882 Ion exchanging of drug delivery |
| 07/03/2001 | US6254879 Quaternariumaminoethylphosphates |
| 07/03/2001 | US6254871 Administering allyl cysteine and allylmercapto cysteine |
| 07/03/2001 | US6254868 Monoclonal antibodies |
| 07/03/2001 | US6254854 Porous particles for deep lung delivery |
| 07/03/2001 | US6254853 Drugs with carriers |
| 07/03/2001 | US6254851 Diagnostic agents for pancreatic exocrine function |
| 07/03/2001 | US6254850 Polycarboxyalkylaminoalkanes for complexes |
| 07/03/2001 | US6254585 Surgical irrigation solution and method for inhibition of pain and inflammation |